September 12, 2019
Rallybio broadens team capabilities by adding Douglas Sheridan, PhD
FARMINGTON, Conn.–(BUSINESS WIRE)–#Rallybio—Rallybio LLC, a development-stage biotechnology company, today announced that it has broadened its drug development capabilities with the…